Future-proof
nuclear medicine
See what's coming next...
Increasing demand
With the rise of PET scan indications and more treatments becoming available, a tsunami of PET studies is coming, while costs of radiotracers and infrastructure remains high.
We are continuously working on our product, and identifying new research directions for developing software solutions that enhance patient outcomes and physician efficiencies at the same time.

The future of nuclear imaging
1. Chronic cancers
Oncology follow-up (S)PE(C)T scans will only increase.
Managing these volumes requires operational excellence & cost-effectiveness.
2. Neurology & new tracers
New tracers & indications will demand more flexible patient scheduling.
High costs & limited reimbursement limit accessibility.
3. Theranostics
Data heterogeneity & quality control in multi-center RCTs are known problems.
Unpredictable prognosis slows down RLT adoption.
Reach out
Product ideas or looking for a software partner in your nuclear medicine project? Please fill in the form.